These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 33778918)

  • 1. Research progress on coronavirus S proteins and their receptors.
    Yuan HW; Wen HL
    Arch Virol; 2021 Jul; 166(7):1811-1817. PubMed ID: 33778918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    Choudhury A; Mukherjee S
    J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spike glycoproteins: Their significance for corona viruses and receptor binding activities for pathogenesis and viral survival.
    Noman A; Aqeel M; Khalid N; Hashem M; Alamari S; Zafar S; Qasim M; Irshad MK; Qari SH
    Microb Pathog; 2021 Jan; 150():104719. PubMed ID: 33373693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets.
    Raghuvamsi PV; Tulsian NK; Samsudin F; Qian X; Purushotorman K; Yue G; Kozma MM; Hwa WY; Lescar J; Bond PJ; MacAry PA; Anand GS
    Elife; 2021 Feb; 10():. PubMed ID: 33554856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A structural view of coronavirus-receptor interactions.
    Reguera J; Mudgal G; Santiago C; Casasnovas JM
    Virus Res; 2014 Dec; 194():3-15. PubMed ID: 25451063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain.
    Antonopoulos A; Broome S; Sharov V; Ziegenfuss C; Easton RL; Panico M; Dell A; Morris HR; Haslam SM
    Glycobiology; 2021 Apr; 31(3):181-187. PubMed ID: 32886791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design.
    Xia X
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33466921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CoV3D: a database of high resolution coronavirus protein structures.
    Gowthaman R; Guest JD; Yin R; Adolf-Bryfogle J; Schief WR; Pierce BG
    Nucleic Acids Res; 2021 Jan; 49(D1):D282-D287. PubMed ID: 32890396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant SARS-CoV-2 S Protein Binds to Glycans of the Lactosamine Family in vitro.
    Ryzhikov AB; Onkhonova GS; Imatdinov IR; Gavrilova EV; Maksyutov RA; Gordeeva EA; Pazynina GV; Ryzhov IM; Shilova NV; Bovin NV
    Biochemistry (Mosc); 2021 Mar; 86(3):243-247. PubMed ID: 33838626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V.
    Bollavaram K; Leeman TH; Lee MW; Kulkarni A; Upshaw SG; Yang J; Song H; Platt MO
    Protein Sci; 2021 Jun; 30(6):1131-1143. PubMed ID: 33786919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
    Ge J; Zhang S; Zhang L; Wang X
    Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing Viruses.
    Nassar A; Ibrahim IM; Amin FG; Magdy M; Elgharib AM; Azzam EB; Nasser F; Yousry K; Shamkh IM; Mahdy SM; Elfiky AA
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
    Fuentes-Prior P
    J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion.
    Dodero-Rojas E; Onuchic JN; Whitford PC
    Elife; 2021 Aug; 10():. PubMed ID: 34463614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure, Function, and Evolution of Coronavirus Spike Proteins.
    Li F
    Annu Rev Virol; 2016 Sep; 3(1):237-261. PubMed ID: 27578435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.
    Pal D
    J Struct Biol; 2021 Jun; 213(2):107713. PubMed ID: 33662570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.
    Fan X; Cao D; Kong L; Zhang X
    Nat Commun; 2020 Jul; 11(1):3618. PubMed ID: 32681106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Questions concerning the proximal origin of SARS-CoV-2.
    Seyran M; Pizzol D; Adadi P; El-Aziz TMA; Hassan SS; Soares A; Kandimalla R; Lundstrom K; Tambuwala M; Aljabali AAA; Lal A; Azad GK; Choudhury PP; Uversky VN; Sherchan SP; Uhal BD; Rezaei N; Brufsky AM
    J Med Virol; 2021 Mar; 93(3):1204-1206. PubMed ID: 32880995
    [No Abstract]   [Full Text] [Related]  

  • 20. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.
    Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T
    mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.